Operating income decreased 135.7%
Operating income changed -135.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -135.7% from the comparable as-filed period.
Operating cash flow changed -68.6% from the comparable as-filed period.
Shares outstanding changed -88.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -96.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -9861 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +47.2% from the comparable as-filed period.
Cash & equivalents changed -96.8% from the comparable as-filed period.
Stock-based compensation changed -41.0% from the comparable as-filed period.
Current liabilities changed +2504.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Total assets changed +1110.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Working capital changed -209.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +3.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.